Trial Profile
A Single-Center, Retrospective Cohort Study Investigating the Cardiac Safety of Trastuzumab Based Therapy in Patients with HER2-Positive Early-Stage Breast Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Carboplatin; Cyclophosphamide; Docetaxel; Fluorouracil; Methotrexate; Paclitaxel
- Indications Early breast cancer; HER2 positive breast cancer
- Focus Adverse reactions
- 11 Jul 2018 New trial record